Paul Paik, MD
Catherine Shu, MD
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping…
Jyoti D. Patel, MD, FASCO
Patient-Centered Discussions and Shared Decision-Making in the Management of NSCLC with METex14 Skipping Mutations
Patient-Centered Discussions and Shared Decision-Making in the Management of NS…
Lyudmila Bazhenova, MD
Benjamin Levy, MD
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
Loading...
Stay current with the best on medical education
Learn More
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.